Fingerprint
Dive into the research topics of 'Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically